Geneva Area, Switzerland
Clinical science leader, translational and personalized medicine
Pharmaceuticals
Education
London Business School 2012 — 2012
Biopharma program
Duke University School of Medicine
Genetics of complex diseases
University Paris VII
PhD, Human Biology, Pharmacology and Haematology
University of Leuven
Université Paris Descartes
DEA
Experience
NovImmune September 2012 - Present
Merck Serono July 2008 - September 2012
Serono International 2004 - July 2008
Sanofi-Synthelabo 2000 - 2004
INSERM 1997 - 2000
Ciba-Geigy 1996 - 1996
Skills
Molecular Biology, Pharmacogenetics, Toxicology, Assay Development, clinical development, IND, Cell, Biomarkers, Cancer, Biotechnology, Neurodegenerative..., Pharmacokinetics, Personalized Medicine, Clinical Development, Translational Research, Regulatory Submissions, Clinical Research, Neurodegeneration, In Vivo, Clinical Trials, Biomarker Discovery, Antibodies, Autoimmune Diseases, Pharmacology, Cell Biology, Monoclonal Antibodies, High Throughput..., Pharmaceutical Industry, Inflammation, Lifesciences, In Vitro, Neuroscience, CRO, Vaccines, Translational Medicine, Biopharmaceuticals, Genomics, Oncology, Drug Development, Drug Discovery, Immunology, GCP